| Schedule of Basic and Diluted Net Income (Loss) |
The following table sets
forth the computation of the Company’s basic and diluted net loss per share for:
| |
|
Three-months ended September 30, 2018 (Unaudited) |
|
| |
|
Net Loss
(Numerator)
|
|
|
Shares
(Denominator)
|
|
|
Per share
amount
|
|
| Basic loss per share |
|
$ |
(928,888 |
) |
|
|
130,083,598 |
|
|
$ |
(0.01 |
) |
| Effect of dilutive securities—Common stock options and warrants |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Diluted loss per share |
|
$ |
(928,888 |
) |
|
|
130,083,598 |
|
|
$ |
(0.01 |
) |
| |
|
Three-months ended September 30, 2017(Unaudited) |
|
| |
|
Net Loss
(Numerator)
|
|
|
Shares
(Denominator)
|
|
|
Per share
amount
|
|
| Basic loss per share |
|
$ |
(363,156 |
) |
|
|
100,587,843 |
|
|
$ |
(0.00 |
) |
| Effect of dilutive securities—Common stock options and warrants |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Diluted loss per share |
|
$ |
(363,156 |
) |
|
|
100,587,843 |
|
|
$ |
(0.00 |
) |
| |
|
Nine-months ended September 30, 2018 (Unaudited) |
|
| |
|
Net Loss
(Numerator)
|
|
|
Shares
(Denominator)
|
|
|
Per share
amount
|
|
| Basic loss per share |
|
$ |
(3,076,873 |
) |
|
|
125,271,516 |
|
|
$ |
(0.02 |
) |
| Effect of dilutive securities—Common stock options and warrants |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Diluted loss per share |
|
$ |
(3,076,873 |
) |
|
|
125,271,516 |
|
|
$ |
(0.02 |
) |
| |
|
Nine-months ended September 30, 2017 (Unaudited) |
|
| |
|
Net Loss
(Numerator)
|
|
|
Shares
(Denominator)
|
|
|
Per share
amount
|
|
| Basic loss per share |
|
$ |
(1,197,035 |
) |
|
|
92,513,317 |
|
|
$ |
(0.01 |
) |
| Effect of dilutive securities—Common stock options and warrants |
|
|
- |
|
|
|
- |
|
|
|
- |
|
| Diluted loss per share |
|
$ |
(1,197,035 |
) |
|
|
92,513,317 |
|
|
$ |
(0.01 |
) |
|
| Schedule of Computation of Diluted Net Income (Loss) Per Share |
The following outstanding
shares of common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented because
including them would have been antidilutive for the periods ended:
| |
|
September
30, 2018
|
|
|
September
30, 2017
|
|
| |
|
(Unaudited) |
|
|
(Unaudited) |
|
| Common stock options |
|
|
39,496,761 |
|
|
|
36,838,427 |
|
| Common stock warrants |
|
|
118,148,846 |
|
|
|
127,018,546 |
|
| Total common stock equivalents |
|
|
157,645,607 |
|
|
|
163,856,973 |
|
|